These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9526806)

  • 1. Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):1B-6B. PubMed ID: 9526806
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.
    Ellen RL; McPherson R
    Am J Cardiol; 1998 Feb; 81(4A):60B-65B. PubMed ID: 9526816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum triglycerides and clinical benefit in lipid-lowering trials.
    Kesäniemi YA
    Am J Cardiol; 1998 Feb; 81(4A):70B-73B. PubMed ID: 9526818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of low-density-lipoprotein lowering with statins.
    Seidel D; Cremer P
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy studies].
    Pedro-Botet J; Flores-Le Roux JA
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():17-9. PubMed ID: 25043542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of niacin, statins, and resins in patients with combined hyperlipidemia.
    Brown BG; Zambon A; Poulin D; Rocha A; Maher VM; Davis JW; Albers JJ; Brunzell JD
    Am J Cardiol; 1998 Feb; 81(4A):52B-59B. PubMed ID: 9526815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin.
    Illingworth DR; Erkelens DW; Keller U; Thompson GR; Tikkanen MJ
    Lancet; 1994 Jun; 343(8912):1554-5. PubMed ID: 7911877
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of statins in hypertriglyceridemia.
    Stein EA; Lane M; Laskarzewski P
    Am J Cardiol; 1998 Feb; 81(4A):66B-69B. PubMed ID: 9526817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of simvastatin and lovastatin/extended- release niacin to achieve LDL and HDL goal using NHANES data.
    Armstrong EP; Zachry WM; Malone DC
    J Manag Care Pharm; 2004; 10(3):251-8. PubMed ID: 15228376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes.
    Kazama H; Usui S; Okazaki M; Hosoi T; Ito H; Orimo H
    Diabetes Res Clin Pract; 2003 Mar; 59(3):181-9. PubMed ID: 12590014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2011 Jul; 108(1):40-6. PubMed ID: 21565322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials.
    Edwards JE; Moore RA
    BMC Fam Pract; 2003 Dec; 4():18. PubMed ID: 14969594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P; Kafonek S; Laurora I; Hunninghake D
    Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which statin is more efficient? Concepts and applications in economic evaluation].
    García-Altés A; Jovell AJ
    Aten Primaria; 2000 Sep; 26(5):333-8. PubMed ID: 11100606
    [No Abstract]   [Full Text] [Related]  

  • 15. [New possibilities of correction of hypercholesterolemia in patients with diabetes mellitus].
    Pan'kiv VI
    Lik Sprava; 2014; (5-6):56-67. PubMed ID: 25906648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-fibrate combinations in patients with combined hyperlipedemia.
    Athyros VG; Papageorgiou AA; Kontopoulos AG
    Atherosclerosis; 2001 Mar; 155(1):263-4. PubMed ID: 11293392
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.
    Vega GL; Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):36B-42B. PubMed ID: 9526812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antilipemic agents in combined therapy].
    Márk L; Császár A
    Orv Hetil; 2002 Aug; 143(34):1973-8. PubMed ID: 12422650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.